載入...
Grade 3/4 neutropenia is a limiting factor in second-line FOLFIRI following FOLFOX4 failure in elderly patients with metastatic colorectal cancer
Previous studies have reported improved outcomes for elderly patients with metastatic colorectal cancer (mCRC) treated with oxaliplatin or irinotecan as first-line chemotherapy. However, few studies regarding second-line chemotherapy with oxaliplatin or irinotecan are currenlty available. We analyze...
Na minha lista:
Main Authors: | , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
D.A. Spandidos
2011
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3410456/ https://ncbi.nlm.nih.gov/pubmed/22866109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2011.260 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|